Trademark Attorney / Law Firm

James Elam – Trademark Portfolio

James Elam has filed 3 trademarks with the United States Patent and Trademark Office (USPTO). Filing records span from 2008 to 2011, covering 2 years of intellectual property practice. The portfolio covers 3 Nice Classification classes, with the highest concentration in Class 35 (Advertising & Business, 1 filings) and Class 41 (Education & Entertainment, 1 filings).

3 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

James Elam's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has James Elam filed?

James Elam has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does James Elam specialize in?

James Elam has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

How long has James Elam been filing trademarks?

James Elam's trademark filing history with the USPTO spans from 2008 to 2011, covering 3 years of trademark practice. During this period, James Elam has handled 3 trademark applications.

What is James Elam's trademark registration success rate?

James Elam has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.